Stay updated on Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Sign up to get notified when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    - Revision history now shows an added v3.5.2 entry and a removed v3.5.0 entry. - The page content and layout remain unchanged.
    Difference
    0.1%
    Check dated 2026-04-16T10:35:24.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    New record history entry for Study Status was added on 2026-03-11 (version 35, Revision: v3.5.0). The earlier revision 3.4.3 was removed on 2026-03-05.
    Difference
    0.3%
    Check dated 2026-03-18T17:47:16.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    New Study Status entry added to the record history. The page revision updated to v3.4.3 and the previous v3.4.2 revision was removed.
    Difference
    0.3%
    Check dated 2026-03-11T14:17:14.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.4.2' was added to the history, and a government funding/operating-status notice was removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:36:33.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a site-wide notice about funding and operating status, and updated the revision to v3.4.1, replacing the previous revision note v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-03T23:37:53.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The history page now includes a glossary option and color-coded indicators for additions and deletions, plus a revision banner (v3.4.0). The text 'No FEAR Act Data' appears with capitalization changes and the revision reference updated from v3.3.4 to v3.4.0.
    Difference
    0.7%
    Check dated 2026-01-27T21:08:35.000Z thumbnail image

Stay in the know with updates to Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.